The intraocular pressure rise that can complicate the use of topical or systemic corticosteroid
has been recognised for 50 years. More recently, following isolation of the myocilin gene …

Steroids in susceptible individuals can cause a clinical condition similar to primary open-
angle glaucoma. Five percent of the population are high steroid responders and develop an …

The intraocular pressure response to topical betamethasone appears to be genetically
determined. A study of patients with primary open-angle glaucoma, their relatives, glaucoma …

Corticosteroid-induced ocular hypertension and glaucoma has been recognized for more
than 50 years. Knowing the risk factors, prevalence, and pathophysiology can help the …

Topical ophthalmic, oral, and intravenous corticosteroids have long been associated with
ocular side effects. Recent data suggest that inhaled corticosteroids are also associated with …

Corticosteroids, used prudently, are one of the most potent and effective modalities available
in the treatment of ocular inflammation. However, they can produce a plethora of adverse …

Purpose: To analyze the incidence, risk factors, and time course of intraocular pressure
elevation after intravitreal dexamethasone implant (Ozurdex). Methods: The medical charts …

PURPOSE: To determine the effects of glucocorticoid treatment on the microfilament
structure of cultured human trabecular meshwork cells. Topical or systemic administration of …

Steroids are invaluable agents in the treatment of a diverse spectrum of disorders; however,
their use is not without risks. Topical, periocular, and systemic steroids may cause ocular …

The effect of topical application of dexamethasone 0.1 per cent eye drops to one eye was
studied in 80 subjects with clinically normal eyes. The change in measures pertaining to …